Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 637 word(s) 637 2020-12-15 07:16:23

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Yang, C. Ataxia-pancytopenia Syndrome. Encyclopedia. Available online: https://encyclopedia.pub/entry/4824 (accessed on 14 April 2024).
Yang C. Ataxia-pancytopenia Syndrome. Encyclopedia. Available at: https://encyclopedia.pub/entry/4824. Accessed April 14, 2024.
Yang, Catherine. "Ataxia-pancytopenia Syndrome" Encyclopedia, https://encyclopedia.pub/entry/4824 (accessed April 14, 2024).
Yang, C. (2020, December 24). Ataxia-pancytopenia Syndrome. In Encyclopedia. https://encyclopedia.pub/entry/4824
Yang, Catherine. "Ataxia-pancytopenia Syndrome." Encyclopedia. Web. 24 December, 2020.
Ataxia-pancytopenia Syndrome
Edit

Ataxia-pancytopenia syndrome is a rare condition that affects the part of the brain that coordinates movement (the cerebellum) and blood-forming cells in the bone marrow. The age when signs and symptoms begin, the severity of the condition, and the rate at which it worsens all vary among affected individuals.

genetic conditions

1. Introduction

People with ataxia-pancytopenia syndrome have neurological problems associated with a loss of tissue (atrophy) and other changes in the cerebellum. These problems include poor coordination and balance (ataxia), difficulty with movements that involve judging distance or scale (dysmetria), uncontrollable muscle contractions (clonus), and involuntary back-and-forth eye movements (nystagmus). These neurological issues worsen over time, making walking and other movements challenging. Some affected individuals eventually require wheelchair assistance.

Ataxia-pancytopenia syndrome also causes a shortage of one or more types of normal blood cells: red blood cells, white blood cells, and platelets. A shortage of all three of these cell types is known as pancytopenia. Pancytopenia can result in extreme tiredness (fatigue) due to low numbers of red blood cells (anemia), frequent infections due to low numbers of white blood cells (neutropenia), and abnormal bleeding due to low numbers of platelets (thrombocytopenia). Ataxia-pancytopenia syndrome is also associated with an increased risk of certain cancerous conditions of the blood, particularly myelodysplastic syndrome and acute myeloid leukemia.

2. Frequency

Ataxia-pancytopenia syndrome appears to be very rare. At least 25 affected individuals from four families have been described in the medical literature.

3. Causes

Ataxia-pancytopenia syndrome is caused by inherited mutations in the SAMD9L gene. The protein produced from this gene is involved in regulating the growth and division (proliferation) and maturation (differentiation) of cells, particularly cells in the bone marrow that give rise to blood cells. Studies suggest that the SAMD9L protein acts as a tumor suppressor, keeping cells from growing and dividing too rapidly or in an uncontrolled way. The SAMD9L protein also appears to play an important role in the brain, particularly the cerebellum, although less is known about the protein's function there.

The mutations that cause ataxia-pancytopenia syndrome are described as "gain-of-function." They increase the SAMD9L protein's ability to block cell growth and division. In the bone marrow, the resulting reduction in cell proliferation leads to a shortage of red blood cells, white blood cells, and platelets. It is unclear how the effects of these mutations are related to ataxia and the other neurological problems associated with ataxia-pancytopenia syndrome.

It seems paradoxical that gain-of-function mutations in the SAMD9L gene, which enhance the protein's tumor suppressor function, could increase the risk of developing cancerous conditions such as myelodysplastic syndrome and acute myeloid leukemia. It appears that certain cells in the bone marrow with an inherited gain-of-function SAMD9L gene mutation can develop additional genetic changes that are associated with milder pancytopenia but an increased cancer risk. These changes include mutations that disable the SAMD9L gene ("loss-of-function" mutations) or a deletion of part of the long (q) arm of chromosome 7 that contains the SAMD9L gene. These additional changes compensate for the effects of the gain-of-function mutation in bone marrow cells. They prevent an overactive SAMD9L protein from excessively restricting cell proliferation, which reduces the severity of pancytopenia in affected individuals. However, a loss of the SAMD9L gene and other genes on the long arm of chromosome 7 may allow cells to grow and divide uncontrollably, leading to cancer. A deletion of the long arm of chromosome 7 is a well-known risk factor for myelodysplastic syndrome and leukemia.

4. Inheritance

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In all reported cases, an affected person has had one parent with the condition.

5. Other Names for This Condition

  • ATXPC
  • myelocerebellar disorder

References

  1. Chen DH, Below JE, Shimamura A, Keel SB, Matsushita M, Wolff J, Sul Y,Bonkowski E, Castella M, Taniguchi T, Nickerson D, Papayannopoulou T, Bird TD,Raskind WH. Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations inSAMD9L. Am J Hum Genet. 2016 Jun 2;98(6):1146-1158. doi:10.1016/j.ajhg.2016.04.009.
  2. Li FP, Hecht F, Kaiser-McCaw B, Baranko PV, Potter NU. Ataxia-pancytopenia:syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acutemyelogenous leukemia. Cancer Genet Cytogenet. 1981 Nov;4(3):189-96.
  3. Li FP, Potter NU, Buchanan GR, Vawter G, Whang-Peng J, Rosen RB. A family withacute leukemia, hypoplastic anemia and cerebellar ataxia: association with bonemarrow C-monosomy. Am J Med. 1978 Dec;65(6):933-40.
  4. Tesi B, Davidsson J, Voss M, Rahikkala E, Holmes TD, Chiang SCC,Komulainen-Ebrahim J, Gorcenco S, Rundberg Nilsson A, Ripperger T, Kokkonen H,Bryder D, Fioretos T, Henter JI, Möttönen M, Niinimäki R, Nilsson L, Pronk CJ,Puschmann A, Qian H, Uusimaa J, Moilanen J, Tedgård U, Cammenga J, Bryceson YT.Gain-of-function SAMD9L mutations cause a syndrome of cytopenia,immunodeficiency, MDS, and neurological symptoms. Blood. 2017 Apr20;129(16):2266-2279. doi: 10.1182/blood-2016-10-743302.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 426
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020
1000/1000